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Organs-on-chip technology has recently emerged as a promising tool to generate
advanced cardiac tissue in vitro models, by recapitulating key physiological cues
of the native myocardium. Biochemical, mechanical, and electrical stimuli have
been investigated and demonstrated to enhance the maturation of cardiac
constructs. However, the combined application of such stimulations on 3D
organized constructs within a microfluidic platform was not yet achieved. For this
purpose, we developed an innovative microbioreactor designed to provide a
uniform electric field and cyclic uniaxial strains to 3D cardiac microtissues,
recapitulating the complex electro-mechanical environment of the heart. The plat-
form encompasses a compartment to confine and culture cell-laden hydrogels, a
pressure-actuated chamber to apply a cyclic uniaxial stretch to microtissues, and
stainless-steel electrodes to accurately regulate the electric field. The platform
was exploited to investigate the effect of two different electrical stimulation pat-
terns on cardiac microtissues from neonatal rat cardiomyocytes: a controlled elec-
tric field [5 V/cm, or low voltage (LV)] and a controlled current density
[74.4mA/cm2, or high voltage (HV)]. Our results demonstrated that LV stimula-
tion enhanced the beating properties of the microtissues. By fully exploiting the
platform, we combined the LV electrical stimulation with a physiologic mechani-
cal stretch (10% strain) to recapitulate the key cues of the native cardiac microen-
vironment. The proposed microbioreactor represents an innovative tool to culture
improved miniaturized cardiac tissue models for basic research studies on heart
physiopathology and for drug screening. VC 2018 Author(s). All article content,
except where otherwise noted, is licensed under a Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). https://doi.org/
10.1063/1.5037968
INTRODUCTION
Unraveling the mechanisms involved in cell differentiation and tissue generation and matu-
ration remains an open challenge in the field of tissue engineering (TE). Organs-on-chip tech-
nology has recently emerged as a powerful tool to recreate tissue-specific physiological micro-
environments not achievable with conventional 2D or 3D cultures.1,2 The ability to mimic
in vitro the native tissue milieus and precisely control the microenvironment has been proved
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as key requirements to regulate cell behaviors and enhance cell function.3,4 Furthermore, minia-
turization offers several advantages in biology, such as a significant reduction in the use of
reagents and cells, allowing for increased experimental throughput in a cost-effective manner.5,6
By exploiting this technology, great effort has been made to develop robust in vitro cardiac
models to provide better insights into heart physiology and pathology in an economically sus-
tainable way.7,8
Biomimetic strategies aimed at providing biochemical and biophysical stimuli specifically
tailored to fully recapitulate key aspects of the complex heterogeneous signals of the local heart
tissue “niche” have been demonstrated to effectively guide tissue development and matura-
tion.9–12 The myocardium is a highly organized 3D tissue in which mechanical forces together
with electrical cues play a key role in promoting the cardiac function.10 In particular, cardio-
myocytes (CMs) in vivo contract in a coordinated fashion, generating a continuous cyclic
mechanical stretch.13–15 This deformation activates mechanosensitive signaling pathways, which
positively affect CM properties and functionality.16,17 Moreover, the complex cell-cell intercon-
nections through gap junctions ensure CM coordinated contraction, whose rhythm is maintained
by pacemaker cells.18 An ideal cardiac in vitro model for developmental biology and drug dis-
covery should present (i) 3D cell-cell and cell-extracellular matrix (ECM) interactions and orga-
nization and (ii) a biomimetic controlled mechanical and (iii) electrical stimulation.19
Microfluidic platforms have been deployed to generate functional cardiac microtissues with
a 3D organization,20 by exploiting the spontaneous cell-cell connections or encapsulating cells
within hydrogels.11,21,22 Cardiomyocytes derived from induced pluripotent stem cells (iPS-CMs)
forming embryoid bodies21 or aligned microtissues12 have been successfully seeded and cul-
tured within microfluidic platforms able to precisely deliver biochemical stimulation. Although
microtissues were successfully generated, the cardiac models resulted in immature, lacking
important structures (e.g., mature sarcomeres and intercalated disks), likely due to the poor
reproduction of typical mechanical and electrical native cues,13,20,23,24 thus limiting their use
for drug screening purposes. The application of a mechanical strain has been demonstrated to
enhance cell organization, maturation, and functionality,9,25 highlighting the connections
between cell mechanics and cell phenotype26 and between cell organization and performan-
ces.27,28 In the attempt to generate more complex microtissues, pairs of predefined structures
(e.g., cantilevers and posts) were exploited as tools to drive the organization of cells embedded
in hydrogels, allowing reproduction of the anisotropic structural orientation of native cardiac
myofibers.11,25,29,30 Moreover, by adjusting the spring constant of the anchoring structures, the
system allowed providing cells with an auxotonic load, reproducing the mechanical cues of the
cardiac environment. However, dedicated channels for medium perfusion were not included in
the platforms, impairing a fine control over the biochemical conditioning. To merge the advan-
tages of microfluidic platforms with the potentiality of enhancing tissue properties by means of
mechanical stimulation, our group developed for the first time an innovative microfluidic plat-
form providing cardiac microtissues with a cyclic mechanical deformation, mimicking the
contraction-relaxation phases experienced by cells in vivo.9 The mechanical training of cardiac
cells resulted in a superior well-defined geometry and mechanical and electrical properties of
the microengineered cardiac tissues with respect to statically cultured microtissues, which were
suitable for drug screening purposes. Furthermore, by exploiting microfluidic channels, a fine
control over biochemical stimulation was also possible.
On the other hand, electrical stimulation has been proven to play a pivotal role, alone or
together with mechanical and biochemical stimulation, in ameliorating the structural and func-
tional properties of the engineered myocardium.31–33 Therefore, several strategies have also
been adopted to combine electrical and mechanical stimulations in a single platform.9,11,33–37 In
particular, electrical systems were designed to either guide cardiac microtissue maturation or
test tissue functionality. These works have some limitations as follows: (i) a non-uniform elec-
tric field on the cell constructs, due to the lack of ad hoc integrated electrical systems,9,25 and
(ii) the lack of consensus about an optimal electrical stimulation protocol for the generation of
mature cardiac models, able to improve the spontaneous and synchronous cardiac beating.9,33,34
Indeed, electrical stimulation of cardiac cells has been pursued by either controlling the external
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electric field or the flowing current. In particular, the most used stimulation patterns have aimed
at imposing either an electric field intensity E of 5 V/cm (2ms, 1Hz)31 or a current density j of
74.4mA/cm2 (2ms, 1Hz).38
Despite great advances in the organs-on-chip technologies, none of the micro-physiological
systems currently developed was able to fully recapitulate the complexity of the cardiac native
milieu. Here, we present an innovative microfluidic platform designed to provide 3D cardiac
microtissues with a controlled biomimetic environment for biochemical, electrical, and mechan-
ical conditioning: lateral medium channels allow for a biochemical conditioning, an integrated
electrical system provides a tightly controlled electric field, and a pressurized chamber ensures
a mechanical stretching of the microtissues. The previously described beating heart on the chip
platform9 was thus equipped with an innovative electrical system compatible with the micro-
scale nature of the device and its peculiar mechanism of mechanical stimulation. In this study,
we exploited the new microfluidic platform to investigate the effect of the two previously men-
tioned electrical stimulation approaches (E¼ 5 V/cm and j¼ 74.4mA/cm2)31,38 on 3D cardiac
microtissues obtained from neonatal rat cardiomyocytes. Furthermore, as proof of concept, we
studied the effect of the combined application of physiological cyclic uniaxial strain
(10%–15%) and electrical stimuli.
RESULTS
Design and fabrication of the microfluidic platform
The microfluidic platform design consists of three different functional elements: (i) a cul-
ture chamber for 3D cell-laden hydrogel culture, (ii) a pressure-actuated compartment providing
a cyclic mechanical stretching to the microtissues by exploiting a previously described tech-
nique,9 and (iii) a pair of stainless-steel electrodes.
The cell culture chamber [Fig. 1(a-i)] is composed of three channels, defined by two rows
of hanging posts with a hexagonal cross-section.9 The central channel hosts the cell-laden
hydrogel during culture, while the lateral channels and reservoirs furnish the culture medium to
the microtissue. Stainless steel electrodes are placed in the lateral medium channels and pre-
cisely positioned parallel to the main axes of the microtissues through specific guides and
anchoring walls. The pressure actuated compartment [Fig. 1(a-ii)] consists of a rectangular
chamber containing 4 rows of circular posts.
The entire platform was produced by assembling multiple layers of polydimethylsiloxane
(PDMS), obtained through soft-lithography techniques. The two compartments are separated by
a thin membrane: the application of a positive pressure in the actuation chamber causes the
stretching of the microtissues,9 while the elastic recoil of PDMS allows to gain its rest position
FIG. 1. (a) Layout of the microfluidic device depicting (i) the cell culture chamber and (ii) the pressure actuated compart-
ment. (b) Detailed microfluidic platform fabrication steps encompassing the electrode insertion, the bonding of the cell cul-
ture layer to the PDMS membrane, and the implementation of the mechanical system by including the pressure-actuated
chamber. (c) Photograph of the final assembled PDMS microscale platform.
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when pressure is released. The location of the electrode pair [Fig. 1(b)] does not perturb the
mechanical actuation system, which ensures a uniaxial strain to the cells of about 12%, as fully
described previously.9 As shown in the picture of Fig. 1(c), the final microscale platform was
equipped with four reservoirs for the cell culture medium, two ports for cell injection, one port
for pressure control, and two copper wires for electrical stimulation.
Electrical characterization of the platform
Finite element methods (FEMs) were used to verify electric field and current density uni-
formity provided within the platform by the parallel configuration of the electrodes. The geo-
metrical domain was modeled as follows: the culture medium as a conductive material (r¼ 1.5
S/m and er ¼ 80.1), the electrodes as a highly conductive material (r ¼ 1.32  106 S/m and er
¼ 1.005), the PDMS hanging posts as good insulators (r ¼ 1022 S/m and er ¼ 2.63), and the
culture compartment walls as perfect electrical insulators [Fig. 2(a-i)]. As shown in Fig. 2(a-ii),
the electric field became uniform in the region occupied by the microtissue, with values around
4.3V/cm for the entire height of the chamber, when 5V/cm was applied. Either higher (5.5V/
cm) or lower (4V/cm) values were computed in the lateral regions, corresponding to the gaps
between or underneath posts or nearby the posts themselves, respectively. However, as evi-
denced in the plot of Fig. 2(a-ii), the electric field values remain rather constant throughout the
height of the central channel region.
Similar results were obtained for the current density distribution [Fig. 2(a-ii)]. A uniform
value for the current density (about 60mA/cm2) was achieved in the inner part of the cell cul-
ture channel. In the outer regions, values ranging between 75mA/cm2 and 35mA/cm2 were due
to the presence of hanging posts. In the gaps underneath the confinement structures, the values
of the current density increased, coherently with the electric field trend. However, also in this
case, the values of the current density remained substantially constant throughout the total
height of the central channel region.
FIG. 2. (a) FEM electrical analyses performed (i) by modeling the cell culture chamber which comprised the PDMS struc-
ture (insulator), the culture medium (fluid), and the electrode (electrodes). (ii) Uniformity of the electric field and current
density achieved within the platform. (b) Electrical characterization of the device: experimental setup used to provide the
device with a biphasic electrical stimulation of (i) 5 V/cm electric field (LV) and (ii) 74.4mA/cm2 current density (HV),
with the correspondent curves of the measured voltage drop and calculated current within the platform. The values of n¼ 3
devices were plotted, with the correspondent mean.
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An experimental characterization of the electrical system was performed to assess the
actual current flowing within the microfluidic platform. In particular, two different tests were
designed, controlling either the electric field (positive peak value 5V/cm) or the current density
(positive peak value 74.4mA/cm2), by means of biphasic rectangular waves with 2ms duration
and 1Hz frequency, as suggested for cardiac cell stimulation.32
Owing to geometrical considerations (electrode distance of 1.6mm), an electric potential of
0.8V was applied on the external wires to achieve an electric field intensity E¼ 5 V/cm within
the platform. Conversely, an electric potential of 3V on the electrodes was estimated which is
necessary to provide a current density j¼ 74.4mA/cm2. Thus, the electrical stimulation patterns
used will be referred from now on as Low Voltage (LV) and High Voltage (HV) stimulations.
The biphasic stimulations highlighted the complex electrical behavior of the device as a
resistor-capacitor circuit, as evidenced by the exponential trend of the voltage drop and current
curves depicted in Fig. 2(b).
During the LV stimulation, the positive and negative values of the voltages exponentially
reached 0.8V and 0.8V, as expected. The current intensities displayed a positive peak corre-
sponding to the on/off events of the stimulus (mean values are 0.35mA and 0.32mA, respec-
tively) and a higher negative peak in correspondence to the inversion of voltage polarity (mean
value, 0.75mA). The average positive and negative plateau values were obtained to be
0.03mA and 0.06mA, respectively.
Similar results were achieved during HV stimulation. Voltage drops rose to average posi-
tive and negative values of 2.8V and 2.9V, respectively, with exponential trends. Coherently
with LV, the current intensity reached the positive peak of 1.5mA before setting to a plateau
value of 0.65mA and a negative peak of 2.5mA before setting to 0.73mA. The positive
peak due to the inversion of signal polarity rose to 1mA. Moreover, in all tested conditions,
the time constant of the system was lower than 2ms (duration of the applied stimulus), demon-
strating the suitability of our system in providing an efficient electrical stimulation.
Electrical stimulation of cardiac microtissues
To assess the effect of the electrical stimulation, cardiac microtissues were statically cultured
within the platform for 3 days and then electrically stimulated for 2 other days, as depicted in
Fig. 3(a). The initial cell population used to generate the cardiac microtissues was mainly com-
posed of cardiomyocytes (70.3%6 2.4%), identified by the cardiac Troponin I and by a smaller
fraction of cardiac stromal cells (29.7%6 2.4%), stained through vimentin [Fig. 3(b)].
After seeding, cells were monitored to evaluate the development of the microtissues, as
shown in Fig. 3(b). In detail, the day after seeding cells appeared mostly round, with some ini-
tial sprouting. Already at day 3, they started elongating and forming connections with neighbor-
ing cells, and at day 5, they assumed an elongated shape and an intrinsic high cell-cell intercon-
nection within microtissues in all conditions [Fig. 3(b)].
In Fig. 4(a), the majority of the cells were alive after 5 days in culture, as evidenced by the
Calcein AM and ethidium staining, and no statistical differences were estimated between the
two provided electrical stimulations since the percentage of live cells was obtained to be
91.9%6 0.05% and 98.1%6 0.04% for the LV and HV, respectively. A slightly higher concen-
tration of cardiomyocytes was observed nearby the posts [Fig. 4(a)].
Cardiac Troponin I immunofluorescence staining in Fig. 4(b) evidences that CM showed
the typical elongated and rod-like shape in both electrically stimulated and control conditions,
as well as visible cytoskeletal striations.
These findings were supported by the functional evaluation of the microtissues, which was
assessed by analyzing beating parameters upon pacing tests [Fig. 5(a)]. In particular, the
Excitation Threshold (ET), defined as the minimum voltage to induce microtissue synchronous
beating with a pacing signal, and the Maximum Capture Rate (MCR), the maximum frequency at
which the microtissues synchronously beat following the pacing, were evaluated. Both electrically
stimulated microtissues showed a lower ET (2.96 0.7 V and 3.46 0.5 V for the LV and HV
stimulations, respectively) as compared to the control group (3.86 0.87 V), evidencing a higher
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cell excitability. Notably, differences in the ET value from LV and control microtissues were sta-
tistically significant, demonstrating a higher electrical connection between cells due to stimulation.
The superior electrical coupling achieved was also confirmed by the MCR parameter, which was
statistically enhanced in LV stimulation (5.676 0.74Hz) as compared to both HV (4.66 0.6Hz)
and control (4.56 0.5Hz). In Fig. 5(b), the analyses on the beating of microtissues during pacing
at 1Hz revealed an enhanced percentage of the contracting area in stimulated tissues, without an
apparently preferential orientation [Fig. 5(c)]. Furthermore, the peak velocity during beating [Fig.
5(d)] increased for LV microtissues (5.86 0.9lm/s), as compared to HV (4.96 1.2lm/s) and
control (46 1.5lm/s). Calcium transient analyses revealed a synchronized beating of the con-
struct in all conditions. Moreover, in both LV and HV microtissues, the calcium transient ampli-
tude was higher with respect to the controls, whose values were 3-fold lower (SI 3).
Cardiac microtissues were preliminary tested for the response to isoprenaline, a non-
selective b-adrenoreceptor agonist commonly used to treat bradycardia. In Fig. SI 4(a), it is evi-
denced how the spontaneous beating frequency of cardiac microtissues increased in a dose
dependent manner in all the condition tested. Moreover, the contraction velocity in both sponta-
neously beating and paced constructs seemed to increase at high isoprenaline concentrations
(from 10 nM to 1000 nM), for control and LV conditions. Such a trend was less evident in the
HV condition [Figs. SI 4(b) and SI 4(c)].
Electro-mechanical stimulation of cardiac microtissues
Both mechanical9 and electrical stimulations independently demonstrated to enhance car-
diac microtissue functionalities within our system. Therefore, as proof of concept, to better
FIG. 3. (a) Experimental plan showing that cells are seeded in the devices, electrically stimulated after 3 days of static cul-
ture and analyzed at day 5. (b) The initial cell population is composed of cardiomyocytes (70.3%6 2.4%) and cardiac stro-
mal cells (29.7%6 2.4%) as quantified from immunofluorescence images. Once embedded in fibrin gel and cultured in the
platform, they start elongating and connecting. The scale bar is 100lm.
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mimic the in vivo cardiac environment, we combined the previously described mechanical
strain9 with the LV electrical stimulation. The mechanical stretching of 10% (500ms duration,
1Hz) and 5V/cm electric field (2ms duration, 1Hz) were synchronized, as sketched in Fig.
6(a), to start the electrical stimuli (systole) when the mechanical actuation switches off (end of
diastole).
Bright field images in Fig. 6(b) showed cell elongation and interconnections in all condi-
tions after 2 days of stimulation (day 5 of culture), confirming previous findings. In particular,
the cardiomyocyte morphology evidenced a better rod-like shape only in stimulated conditions
(electrical, mechanical, and electro-mechanical) as compared to control.
Pacing tests [Fig. 6(c)] demonstrated an enhanced cardiac microtissue functionality
achieved through electrical (5V/cm, 1Hz), mechanical (10% stretch, 1Hz), or electro-
mechanical stimulation. Indeed, ET was found to be statistically lower in all stimulated condi-
tions, being 2.96 0.7 V for electrically stimulated microtissues, 2.56 0.5 V for mechanically
stretched constructs, and 2.56 0.7 for cardiac microtissues under electro-mechanical stimula-
tion, as compared to control (3.76 0.71 V). Although mechanical and electro-mechanical
microtissues showed higher beating frequency as compared to control (5.36 0.6Hz,
5.16 1.1Hz, and 4.56 0.5Hz, respectively), only the electrical stimulation condition was found
to generate statistically different MCR values (5.76 0.7Hz).
DISCUSSION
The microfluidic platform presented in this study integrates all key-physical cues present in
the native cardiac environment (i.e., biochemical, mechanical, and electrical). The enhancement
of the maturation level of cardiac microtissues represents a strict requirement for the generation
of robust cardiac in vitro models.39 Different strategies demonstrated that the mechanical and
electrical properties of the myocardium promote cellular growth, orientation, maturation, and
overall structural tissue organization.4,9,16,33
FIG. 4. (a) Live and dead staining and quantification, evidencing similar cell viability in both control and electrically stimu-
lated microtissues after 5 days in culture. (b) Immunofluorescent staining of cardiac Troponin I and Connexin-43, highlight-
ing the typical rod-like shape of cardiomyocytes and the expression of electrical gap-junctions after 5 days in culture.
Arrows indicate the cell striation and arrow heads the gap junctions at the membrane. The scale bar is 100lm.
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The active cyclic mechanical strain has been fully exploited in 2D systems, where cells
were cultured on flat deformable membranes.40,41 However, the typical complex 3D organiza-
tion of the cardiac tissues was not fully recapitulated, impairing the investigation of representa-
tive cell-cell or cell-matrix interactions. In the attempt to overcome these limitations, a
technique relying on the self-organization of cell-embedded hydrogel microtissues for the gen-
eration of cardiac microwires (CMWs) was introduced by Legant et al.30 Briefly, cells were
embedded in collagen or fibrin hydrogels and cast into PDMS molds containing flexible struc-
tures such as microscale cantilevers or micro-posts. During cell remodeling of the matrices, tis-
sue collapsing and anchoring to the structures caused their deflection, proportional to cardiac
microtissue development and beating,11,25 exerting in turn an auxotonic load to cells. This ele-
gant strategy was also implemented in a 96-well device,42 demonstrating the potentiality of the
system to generate functional human cardiac organoids for high-throughput studies in human
FIG. 5. (a) Pacing tests performed to assess the ET and MCR parameters, indicating microtissue electrical excitability. (b)
Representative color maps of the time-averaged beating motions of the control and electrically stimulated microtissues after
5 days in culture, paced at 1Hz. The scale bar is 100lm. (c) Percentage of the area of the microtissue involved in the con-
traction and (d) directionality of the beating. (e) Microtissue beating peak velocities.
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biology and drug screening. In this contest, merging the concept of miniaturization with
mechanical cues, our group recently developed a new biomimetic platform for culturing 3D
fibrin-based cardiac microtissues, which enhances their maturation by means of active physio-
logical cyclic mechanical strain.9 The key feature relied on the integration within a microfluidic
device of a mechanical system, which allowed converting a pressure signal into a controlled
uniform uniaxial strain applied to the 3D microtissues.
Besides mechanical cues, electrical stimulation has been largely exploited to develop car-
diac tissues with enhanced conductive and contractile properties, leading to a better ultrastruc-
tural organization.21,32,33,43 The most commonly adopted engineering solutions to perform elec-
trical stimulations are either carbon rods or platinum electrodes integrated into macroscale
systems. Although efficient, these electrodes cannot be easily integrated within the microfluidic
platforms, impairing the possibility to accurately control the uniformity of the generated electric
field.44 Multi-electrodes arrays (MEAs)45 and other microelectrodes systems46 overcome these
limitations, but their planar nature inhibits the achievement of uniform electrical stimulation in
3D microtissues. The first example of 3D electrodes integrated within microfluidic platforms
was presented in a study by Pavesi et al.,47,48 in which a conductive PDMS/carbon nanotube
mixture was cast into a silicone mold and successfully integrated within a microfluidic plat-
form. However, the overall process became long and complex, and such geometry still did not
allow to culture 3D cell microtissues.
FIG. 6. (a) Experimental plan showing that after seeding, cells are statically cultured for 3 days, and then the electrical (5
V/cm), mechanical (10% stretch, 1Hz), or electro-mechanical stimulations were started. At day 5, all the analyses were
performed. (b) Cell morphology assessed after 5 days of cultures, with higher magnification insets showing elongated cells.
The scale bar is 100lm. (c) Pacing tests performed to evaluate microtissue electrical excitability, through ET and MCR
parameters.
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Aiming at reproducing the complexity of the stimulation that cardiac cells experience
in vivo, we here developed a biomimetic microfluidic platform, providing cells with a 3D envi-
ronment in which biochemical, mechanical, and electrical features can be tailored to guide
microtissue maturation. The platform relies on the integration of a couple of micro-stainless-
steel electrodes that are directly and easily integrated within the microfluidic platform during
the fabrication process. The design of the platform was maintained compatible with the previ-
ously optimized mechanical system, so as to equip the microfluidic device with both electrical
and mechanical stimulations. The system was exploited to investigate the effect of electrical
stimulation on cardiac microtissues, comparing the effect of two of the most effective strategies
used at the macroscale to culture neonatal rat cardiomyocytes: applying a uniform electric field
(i.e., 5 V/cm) or a uniform current density (i.e., 74.4mA/cm2).
Since the electrical stimulation was the main feature added to the platform, a characteriza-
tion of important electrical parameters was performed, while the mechanical characterization is
fully detailed in our previous work.9 A FEM numerical model allowed us to confirm the gener-
ation of a uniform electric field over the hydrogel channel region with field perturbation only
around the hanging post structures. The computational analyses were made by assuming steady
state conditions, in agreement with previously reported studies,38 providing information about
the spatial distribution of the electric field and current density. Moreover, to assess the dynam-
ics of the involved electrical processes, an experimental characterization study was performed,
highlighting the complex behavior of the system as a resistor-capacitor circuit. The electric cur-
rent flowing in the device indeed reached a maximum value at the beginning of the pulse (posi-
tive or negative pulse) and then set to a plateau value. This is in line with previously reported
works, evidencing complex phenomena occurring at the electrode-electrolyte interface associ-
ated with the use of solid electrodes in contact with the culture medium.38,49,50 The experimen-
tal characterization study allowed us to validate the stainless-steel electrode configuration as a
suitable system to provide an efficient electrical stimulation within the microfluidic platform
since the time constant of the system was lower than 2ms (duration of the applied stimulus).
Furthermore, it was possible to define the necessary voltage drop to achieve the pre-defined
74.4mA/cm2 within the microfluidic platform, allowing for performing all cellular experiments
with a voltage control stimulation, ensuring comparison between the electric field and current
density conditions.
The platform was suitable to generate microtissues with well-defined dimensions, deter-
mined by the main channel geometry (300 lm width, 150 lm height, and 10mm long), from
neonatal rat cardiomyocytes. Both electrical stimulations were extremely low cytotoxic,
confirming the suitability of the use of stainless-steel electrodes for electrical stimulation. The
analyses on microtissue beating revealed that both electrical stimulations improved the respon-
siveness of the microtissues to an external pacing, as evidenced by the lower excitation thresh-
old and higher maximum capture rate achieved. These results are in agreement with previously
reported works both at the macro- and micro-scales.32,51 However, the application of the lower
electric field (LV), defined as characteristic for the native myocardium,32 was more suitable to
improve cell-cell coupling, statistically enhancing ET and MCR parameters, respect to control,
and statistically increasing the MCR parameter compared to current density stimulation.
Electrical stimulation increased cellular interconnections, enhancing the uniformity of the gener-
ated microtissues, as demonstrated by the higher percentage of the contracting area involved in
the beating motion. Furthermore, the overall beating peak velocity was enhanced by electrical
stimulation, as already shown for mechanical stimulation within our platform.9 The values of
the beating velocity of microtissues achieved with electric field stimulation were comparable
with previously reported data on the human cardiac construct cultured in a 3D environment
within a micro-physiological platform,12 even if a predominant beating direction was not evi-
denced in our system. Calcium transient analyses revealed a synchronized beating of the con-
struct in all conditions. Moreover, in both LV and HV microtissues, the calcium transient
amplitude was higher with respect to the controls, whose values were 3-fold lower (SI 3).
These preliminary curves showed the compatibility and the potentiality of the platform to assess
important parameters to characterize the calcium dynamics of 3D cardiac microtissues, such as
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the time to peak, the decay time, and peak height. Moreover, we preliminary exploited the plat-
form to perform drug screening tests, by assessing the positive chronotropic effect of the iso-
prenaline on the cardiac constructs, as previously reported.9 Although variations of contraction
velocity were observed based on drug concentration, further experiments are still required to
better evaluate a dose-dependent effect.
To fully exploit the capabilities of the designed microfluidic platform as an innovative tool
to perform biological studies, a pivotal experiment was performed to elucidate the effect of the
combination of the electric field stimulation and cyclic mechanical deformation (electro-
mechanical condition). In particular, starting the electrical pulse when the mechanical load is
turned off mimics the in vivo isovolumic contraction of the heart.52 During a cardiac cycle,
blood fills the ventricles, causing a stretch of the myocardium which is then electrically stimu-
lated to contract (without relaxing) to generate the right pressure to pump blood through aortic
or pulmonary valves. According to a study performed on cardiac ring-shape microtissues from
fibrin gel stretched and subjected to electrical stimulations,52 the use of combined stimuli
enhances the beating characteristics of the microtissues. Indeed, microtissues stimulated both
electrically and mechanically showed statistically lower ET values as compared to control and
were comparable with those achieved with either electrical or mechanical stimulation alone.
However, the MCR did not reach values comparable to those in electric field stimulated micro-
tissues, even if higher than the control. These results could be related to the fact that the electri-
cal or mechanical stimulations provided alone were already optimized within the microfluidic
platform, while the combination of the stimuli requires further investigation to induce optimal
results.
CONCLUSION
The developed microfluidic platform provides the unprecedented opportunity to precisely
control different environmental cues (i.e., biochemical and physical) so as to generate 3D func-
tional cardiac microtissues. The combination of uniform uniaxial strain and uniform electrical
stimulation (either concurrently or sequentially) could be of fundamental relevance to improve
the generation of more mature and robust in vitro cardiac models, especially envisioning the
use of human induced pluripotent stem cell derived cardiomyocytes.24,35
METHODS
Ethics statement
In this study, cells were isolated from hearts of 2 day-old neonatal Sprague Dawley rats
(Charles River, Wilmington, MA, USA) that were collected from animals involved and eutha-
nized in another study unrelated to the ongoing research. All the applicable international,
national, and/or institutional guidelines for the use of these animals were followed. The
Institutional Animal Care and Use Committee of the San Raffaele Scientific Institute (IACUC
795) approved the study designed for this group of animals. All procedures on animals involved
in this study were in accordance with the ethical standards.
Design and fabrication of the platform
The layout of the layers composing the platform was drawn using CAD software
(AutoCAD, Autodesk Inc.). The central channel of the cell culture chamber is 300 lm wide,
delimited by hexagonal hanging posts. The media channels are 800 lm wide and housed stain-
less steel electrodes (120 lm in diameter) positioned at a distance of 1.6mm. For each layer,
the corresponding optical masks were obtained with a vector graphics editor (Adobe Illustrator
CC, Adobe Systems Incorporated) and printed at high resolution (64 000 DPI) on a polyester
film. Master molds were fabricated in a cleanroom environment (Polifab, Politecnico di
Milano) by means of the conventional photolithography technique. Briefly, the pattern of each
layer was transferred on SU8-2050 photoresist (MicroChem, USA), previously spin-coated on 4
in. silicon wafers. The culture chamber master mold was composed by two layers of photoresist
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[Fig. SI 1(a)]: (i) a 50 lm thin layer representing the cell culture chamber that forms the gap
space between pillars and bottom compartment and (ii) a 100 lm thick layer including the posts
that were aligned on top of the previous culture chamber layer. Specifically, to obtain 50 lm
and 100 lm photoresist layers, the spinning velocity used was 3840 rpm and 1900 rpm, respec-
tively. The pressure actuated compartment is conversely obtained by a single photoresist layer,
50 lm thick [Fig. SI 1(b)], obtained with a velocity of 3480 rpm.
The device was made of PDMS (Sylgard 184, Dow Corning) by mixing the elastomer base
with the curing agent and degassing and casting it on the master molds. After curing (65 C for
3 h), PDMS stamps were peeled off the mold and assembled, by permanently bonding surfaces
with air plasma (Harrick Plasma, Inc.). In detail, holes for media reservoir and ports for hydro-
gel injection were created within the cell culture chamber through biopsy punchers of 5mm
and 750 lm, respectively. Stainless steel electrodes were manually positioned in the stamp
which was subsequently bonded to a PDMS membrane (1mm thick). The access port for the
pressure-actuated compartment was then created by punching a hole of 500lm, and the so-
obtained layer was bonded to the pressure-actuated compartment, after careful alignment.
Electric wires were soldered by means of epoxy conductive resin (RS Components) to the elec-
trodes. The final assembled device was further cured overnight at 80 C to finalize the bonding
process and wire connections.
Finite element analyses
FEM was performed through commercially available software (COMSOL Multiphysics
4.2a, Stockholm, Sweden). The geometry characterizing the cell culture chamber [Fig. 2(a)]
was divided into three domains: (i) the fluid domain, representing the culture medium, (ii) the
electrodes, and (iii) the insulator comprising the PDMS frame and posts. For the medium, elec-
trodes, and PDMS domain, the electrical conductivity of 1.5 S/m, 1.32  106 S/m, and 1022
S/m and the relative permittivity of 80.1, 1.005, and 2.63 were defined.43 Numerical simulations
were performed exploiting the electric current interface, assuming DC and steady state condi-
tions to solve Maxwell’s equations.38,49 Insulation boundary conditions were applied to PDMS
surfaces; stainless steel electrodes were set to ground and 0.8V to simulate the application of a
5V/cm electric field. The electric field and the current density distribution were visualized by
plotting colorimetric maps, while the accurate evaluation of the intensity of the generated elec-
tric field and current density was investigated by plotting the 1D graph at different quotes, cor-
responding to the different height of the microtissues.
Functional characterization of the electrical mechanism
Electrical signals for the electrical characterization of the platform were generated and
recorded through the analogical channels of the data acquisition (DAQ) board (NI USB-6211,
National Instrument, TX, USA), by providing monophasic waves (2ms, 1Hz), which were set
up through a custom-made LabVIEW interface (LabVIEW, National Instrument, TX, USA).
The microfluidic platform was connected in series to a 150X resistor. Voltage drop on both the
microfluidic platform and the resistor was acquired, and the current flowing in the circuit was
calculated by using the Ohm law on the resistor. Two electric potentials were applied to the cir-
cuit, reproducing an electric field of 5V/cm or a current density of 74.4mA/cm2. In the first
case, an electric potential of 0.8V was applied across the electrodes, whose distance is 1.6mm.
In the second case, a preliminary test was performed to obtain the voltage drop on the platform
which ensures a current density of 74.4mA/cm2. In detail, a current of 1mA was calculated to
be necessary flow through the platform, whose cross-section was estimated to be 1.4mm2. This
current was thus applied through the platform, and the corresponding voltage drop of 3V was
acquired. For each device, results were plotted as means of 10 s registration with a sample rate
of 20_000 samples/s. For each test, the average values of voltage drops and of the currents in
the devices were also plotted.
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Development of a custom-made electro-mechanical stimulator
A custom-made control system based on LabView was developed, to interconnect a multi-
purpose DAQ-MX I/O board with the microfluidic devices [Fig. SI 2(a)]. A current amplifier
circuit, made of four Op-Amp in buffer configuration and 8 bipolar junction transistors, was
assembled to increase the output current of the I/O board (limited to 62mA per channel), of
both positive and negative signals.
In particular, the system allowed generating two individually tunable analog square waves
with amplitudes ranging from 60.001V to 610V and frequencies from 0.01Hz to 1 kHz. For
the electrical stimulation, biphasic square waves were generated with 0.4% duty cycle (2ms
positive voltage and 2ms negative voltage and 996ms off). For the pacing tests, monophasic
square waves with 0.4% duty cycle (4ms on and 996ms off) were generated. In addition, a
transistor-transistor logic (TTL) port of the board was used to actuate a solenoid miniaturized
valve connected to the mechanical actuation compartment o the microfluidic platform.9 The
LabView software allowed us to independently control the analog and digital signals so as to
synchronize the electro-mechanical stimulation of cardiac microtissues. The graphical user
interface was conceived to set stimulation parameters, such as the signal amplitude and the fre-
quency, and to capture and plot the platform’s electrical response in real time and to save the
data [Fig. SI 2(b)].
Cardiac cell isolation and characterization
Neonatal rat cardiomyocytes were isolated from 2-days-old Sprague Dawley rats following
the previously described protocol.9 Freshly isolated cells were enriched for cardiomyocytes by
performing a 1 h pre-plating in flasks. The harvested non-adhered cells, which were mostly car-
diomyocytes, were cultured in Dulbecco’s modified essential medium high glucose (DMEM,
4.5 g/l glucose, Gibco) supplemented with 10% v/v fetal bovine serum (FBS, Hyclone), 100U/
ml penicillin (Life Technologies), 100 lg/ml streptomycin (Life Technologies), and 10mM
Hepes (Gibco), defined as the growth medium. Cells were used the day after to generate the
cardiac microtissues. To characterize the initial cell population, cells were also seeded in mono-
layer at a density of 8  104 cells/cm2 on 0.1% w/v gelatin (Sigma Aldrich) coated wells.
Neonatal rat cardiomyocytes and stromal cells were immunofluorescence stained for cardiac
Troponin I (cTnT) and vimentin (Abcam), respectively. Image analysis was exploited to calcu-
late the relative percentage of the two cell populations by normalizing the values over the total
amount of cells, quantified by the 4’,6-diamidino-2-phenylindole (DAPI, Invitrogen) nuclear
staining.
Cardiac microtissue culture and stimulation
To generate the 3D cardiac microtissues, cardiomyocytes were embedded in a fibrin gel at
a density of 75  106 cells/ml and were injected into the microfluidic platform. In detail, a
fibrinogen solution was mixed with the cardiac cells suspended in DMEM containing thrombin
and aprotinin, in order to achieve a final fibrin gel of 20mg/ml fibrinogen, 5 unit/ml of throm-
bin, and 1.6 TIU/ml of aprotinin (all purchased from Sigma Aldrich). The so-obtained cell-
laden fibrin solution was pipetted into the central channel of the culture chamber (2 ll each
device) and incubated for 5min (5% CO2; 37
C) to allow the gel reticulation before adding the
culture medium in the lateral channel. The microtissues were cultured for 5 days in the growth
medium supplemented with 2mg/ml of aminocaproic acid (Sigma). Both types of electrical
biphasic stimulations (fixed electric field of 5V/cm and constant current density of 74.4mA/
cm2) were applied after 3 days in culture. Static cultures of cardiac microtissues were used as
control.
The most suitable electrical stimulation conditions were subsequently exploited to evaluate
the effects of the combined electro-mechanical stimulation. In particular, after 5 days in static
culture, mechanical (mech, 10% uniaxial strain, frequency 1Hz), electrical, or combined
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(electro-mech) stimulations were provided to microtissues after 3 days in culture. Static cultures
of cardiac microtissues were used as control.
Cell viability
To evaluate the cytocompatibility of the microfluidic device and to prove the non-cytotoxic
effect of the provided electrical stimulations, cell viability was assessed on both stimulated and
control microtissues after 5 days in culture. The live/dead assay (Thermo Fisher Scientific) was
performed according to the manufacturer’s protocol. Briefly, the microtissues were washed
twice with pre-warmed PBS, and then, a solution of 2 lM Calcein AM and 4 lM Ethidium
homodimer in phosphate buffered saline (PBS) was perfused within the devices. After
15minutes of incubation at 37 C in the dark, images were acquired by means of a fluorescence
microscope (Olympus IX-71, Olympus Corporation, Tokyo, Japan) at 10 magnification.
Green-labeled live cells and red-stained nuclei of dead cells were quantified using ImageJ soft-
ware, and results were expressed as normalized values respect to the control condition. Three
samples for each condition were considered.
Immunofluorescence staining
Immunofluorescence analyses were performed after 5 days of culture on electrically stimu-
lated microtissues directly within the microdevices to assess cardiac phenotype, maturation
(Troponin I), and electrical coupling (Connexin-43). Samples were fixed in 4% paraformalde-
hyde (PFA) for 15min and incubated with a solution of 0.1% Triton X-100 (Thermo Fisher
Scientific) and 2% bovine serum albumin (BSA, Sigma Aldrich) in PBS for 1 h at room tem-
perature to permeabilize cells and to block nonspecific binding. Primary antibodies, Troponin I
(Santa Cruz) and Connexin-43 (Abcam), were diluted 1:100 and 1:500, respectively, in 0.5%
w/v BSA and incubated overnight at 4 C. Goat anti-mouse (Thermo Fisher Scientific, rhoda-
mine conjugated) and goat anti-rabbit (Thermo Fisher Scientific, FITC conjugated) secondary
antibodies, diluted 1:200 in 0.5% w/v BSA, were incubated in the dark for 6 h at 4 C. DAPI
counterstaining was used to identify cell nuclei, by incubating the dye in PBS for 10minutes at
room temperature.
Microtissue functional analyses
Electrical properties of microtissues were evaluated after 5 days in culture, performing
functional pacing tests. The pacing signal was transferred to the microtissues by means of the
integrated electrodes and consisted of a monophasic pulse of 4ms duration, generated through
the custom-made electrical stimulator, controlled via our Labview interface (Fig. SI 2). The
amplitude (0–12V, with 0.1V resolution) and frequency (1–10Hz) of the signal were adjusted
for each microtissue to measure the excitation threshold (ET) and the maximum capture rate
(MCR), as previously described.9 Data from 10 microtissues, from the N¼ 3 independent
experiments, were analyzed.
Beating microtissues were monitored under a 10 objective lens on an inverted microscope
(Olympus IX-71), and videos were collected through a camera at 23 frames/s to assess the con-
traction amplitude and beating synchronicity of electrically stimulated and control microtissues.
The contraction amplitude and velocity were evaluated by means of a motion tracking software
developed by Healy’s group. Briefly, a region of interest (ROI) was defined for each microtis-
sue, by excluding the regions nearby the posts. The area of the microtissues involved in the
contraction, the mean contraction amplitude along x and y axes, and the mean beating peak
velocity were assessed for 6 microtissues in the N¼ 2 independent experiments.
Calcium transient assay
Assessments on calcium handling of cardiac microtissues in the LV, HV, and control con-
ditions were performed after 5 days in culture. Oregon Green
VR
488 dye (Thermo Fisher
Scientific) at 10 lM in the growth medium was injected in the media channels and incubated in
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the dark at 37 C, 5% CO2 for 90minutes. Fluorescence videos (Figs. SI 5–SI 7) were acquired
using an inverted microscope (Olympus IX-71) equipped with a fast camera (100 frame/s) and
were processed with ImageJ and Origin to generate fluorescence intensity plots. The peak
amplitude, defined as the ratio between peak fluorescence intensity during contraction and base-
line fluorescence (F/F0), was evaluated in both central and lateral parts (near posts) of the
microtissues.
Drug response
Dose–response experiments were performed on cardiac microtissues after 5 days in culture
in LV, HV, and static conditions. Isoprenaline was diluted at different concentrations
(0.001 nM, 0.1 nM, 10 nM, and 1 lM) in the growth medium and added stepwise to the micro-
tissues. After 15minutes of incubation at 37 C in a 5% CO2 environment, the response on the
microtissues was recorded using an inverted microscope (Olympus IX-71), and videos were col-
lected using a fast camera at 100 frame/s. The beating frequency and contraction velocity of
both spontaneously beating and paced constructs (amplitude of 1.5-fold ET and frequency of
1Hz) were evaluated by means of a motion tracking software developed by Healy’s group.
Results are presented as mean 6 standard error for n¼ 3 microtissues.
Statistical analyses
All data were statistically analyzed through GraphPad Prism software (GraphPad Software,
USA). Data were tested for normality and presented and analyzed with mean 6 standard devia-
tion or median with quartile, accordingly. Statistical analyses were performed using Analysis of
Variance (ANOVA) with Tukey’s post-test or Kruskal-Wallis with the Dunn post-test
(*P< 0.05, **P< 0.01, and ***P< 0.001).
SUPPLEMENTARY MATERIAL
See supplementary material for the detailed steps to fabricate the microfluidic platform, the
custom-made control system to perform the electro-mechanical stimulation, calcium transient
assay, and drug response of microtissues. Supplementary videos of calcium transient are also
available.
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